Chemoinformaics analysis of 10,10-DIMETHYL-2,6-DIMETHYLIDENEBICYCLO[7.2.0]UNDECAN-5-OL
Molecular Weight | 220.356 | nRot | 0 |
Heavy Atom Molecular Weight | 196.164 | nRig | 4 |
Exact Molecular Weight | 220.183 | nRing | 2 |
Solubility: LogS | -5.342 | nHRing | 0 |
Solubility: LogP | 5.782 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.419 |
Synth | 3.5 |
Natural Product Likeliness | 2.307 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.822 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.513 |
MDCK | 0.0000209 |
BBB | 0.06 |
PPB | 0.912499 |
VDSS | 2.479 |
FU | 0.0638947 |
CYP1A2-inh | 0.586 |
CYP1A2-sub | 0.13 |
CYP2c19-inh | 0.543 |
CYP2c19-sub | 0.811 |
CYP2c9-inh | 0.387 |
CYP2c9-sub | 0.549 |
CYP2d6-inh | 0.282 |
CYP2d6-sub | 0.067 |
CYP3a4-inh | 0.854 |
CYP3a4-sub | 0.303 |
CL | 11.138 |
T12 | 0.206 |
hERG | 0.03 |
Ames | 0.002 |
ROA | 0.008 |
SkinSen | 0.952 |
Carcinogencity | 0.219 |
EI | 0.555 |
Respiratory | 0.037 |
NR-Aromatase | 0.027 |
Antiviral | Yes |
Prediction | 0.882715 |